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AbstrACt
background A living- donor kidney transplant is the 
best treatment for most people with kidney failure. 
Population cohort studies have shown that lifetime living 
kidney donor risk is modified by sex, age, ethnicity, body 
mass index (BMI), comorbidity and relationship to the 
recipient.
Objectives We investigated whether the UK population of 
living kidney donors has changed over time, investigating 
changes in donor demographics.
Design We undertook a cross- sectional analysis of the 
UK living kidney donor registry between January 2006 
to December 2017. Data were available on living donor 
sex, age, ethnicity, BMI, hypertension and relationship to 
recipient.
setting UK living donor registry.
Participants 11 651 consecutive living kidney donors 
from January 2006 to December 2017.
Outcome measures Living kidney donor demographic 
characteristics (sex, age, ethnicity, BMI and relationship 
to the transplant recipient) were compared across years 
of donation activity. Donor characteristics were also 
compared across different ethnic groups.
results Over the study period, the mean age of donors 
increased (from 45.8 to 48.7 years, p<0.001), but 
this change appears to have been limited to the White 
population of donors. Black donors were younger than 
White donors, and a greater proportion were siblings 
of their intended recipient and male. The proportion of 
non- genetically related non- partner donations increased 
over the 12- year period of analysis (p value for linear 
trend=0.002).
Conclusions The increasing age of white living kidney 
donors in the UK has implications for recipient and donor 
outcomes. Despite an increase in the number of black, 
Asian and minority ethnic individuals waitlisted for a 
kidney transplant, there has been no increase in the ethnic 
diversity of UK living kidney donors. Black donors in the UK 
may be at a much greater risk of developing kidney failure 
due to accumulated risks: whether these risks are being 
communicated needs to be investigated.
IntrODuCtIOn
A living- donor kidney transplant (LDKT) is 
the best treatment in terms of life expectancy 
and quality of life for most people with kidney 
failure.1–7 The healthcare costs associated 
with LDKTs are less than for both dialysis and 
deceased- donor transplants.8 9 LDKTs reduce 
the number of individuals on waiting lists 
for deceased- donor transplants and there-
fore offer the possibility of transplantation 
to more patients, who would otherwise be 
dialysis dependent.10 Research over the last 6 
years has attempted to better define the risks 
of living donation. Population cohort studies 
have suggested that the risks of donating 
a kidney, although real, are very small.11–14 
Absolute 15- year incidence of kidney failure 
for white kidney donors is estimated at 
<1% but donor risk is modified by sex, age, 
ethnicity, body mass index (BMI), comor-
bidity and relationship to the recipient.14
Although UK LDKT activity is in the top 
third worldwide, it falls significantly below 
that of the USA and the Netherlands.15 In 
2017, the LDKT rate in the UK was 15 per 
million population (pmp) compared with 
strengths and limitations of this study
 ► This study is a cross- sectional analysis of the UK liv-
ing donor registry which collects data on the entire 
UK population of living donors.
 ► It has a very large sample size (n=11 651) and the 
amount of missing data was very small.
 ► The study is limited to a descriptive analysis of rou-
tinely collected data.
 ► Comorbidity data are poorly recorded. This limited 
assessment of comorbidity and is something that 
could be addressed to ensure collection of better 
quality, coded comorbidity data.
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18 pmp in the USA, and 32 pmp in the Netherlands.15 
Only 20% of those listed on the UK transplant waiting 
list receive an LDKT each year.4 Certain individuals with 
renal disease appear to be particularly disadvantaged. 
The proportion of Black, Asian and minority ethnic 
(BAME) patients on the kidney- only transplant waiting 
list in the UK has increased.16 However, patients from 
BAME groups wait on average 6 months longer to receive 
a kidney transplant than White patients, and people from 
Black and Asian individuals in the UK are approximately 
40% less likely to receive an LDKT when compared with 
white people with kidney disease.16–18 Older people with 
kidney disease are also less likely to receive an LDKT 
when compared with younger patients,18 and women 
are less likely to receive an LDKT when compared with 
men.19 20
In this study, we analysed UK living donor registry data 
to describe the UK living donor population from the 
last 12 years. The recipients of kidneys from older living 
donors in the USA have been shown to be at higher risk 
of graft loss, compared with recipients of younger living 
donor kidneys.21 The median age of the UK prevalent 
dialysis population is increasing22; we aimed to investigate 
if this was reflected in the living donor population, which 
might have implications for recipient outcomes. Donor 
nephrectomy complication rates have been reported as 
higher in donors with hypertension than those without,23 
and in African Americans compared with other races.24 
We aimed to investigate whether the UK population of 
living kidney donors has changed over time, investigating 
changes in donor demographics including age, ethnicity, 
sex and comorbidity. We aimed to identify whether the 
proportion of donations from higher risk donors has 
changed.
MethODs
study design, setting and data sources
In this large cross- sectional study, we analysed UK living 
donor registry data on all living kidney donations as 
reported to NHS Blood and Transplant (NHSBT) from 
January 2006 to December 2017. Information on every 
living kidney donation that occurs in the UK is collected 
by NHSBT, which is regulated under section 251 of 
the National Health Service (NHS) Act 200625 and the 
Health Service (Control of Patient Information) Regula-
tions 2002.26 As such it has been granted permission by 
the UK’s Secretary of State to collect identifiable patient 
data without individual patient consent. Only anony-
mised data (all patient identifiers removed) was shared 
with the research team.
Patient and public involvement
As this study was a descriptive analysis of routinely 
collected data, the research was undertaken without 
patient and public involvement.
Participants and study size
We included all living kidney donors who had been 
reported to NHSBT between January 2006 and December 
2017. Data were requested, and with permission extracted, 
from the UK Transplant Registry, held by NHSBT. No 
data linkage was required.
Variables
Living kidney donor demographic characteristics (sex, 
age, ethnicity, BMI and relationship to the transplant 
recipient) were extracted and compared for donor 
cohorts across the years of donation activity. Ethnicity 
was coded using the UK’s Office for National Statistics 
2001 census categories: White (White British, White Irish, 
other White), Black or Black British (Black Caribbean, 
African, other Black), Asian or Asian British (Indian, 
Pakistani, Bangladeshi, other Asian), Chinese or other 
ethnic group, mixed (White and Black Caribbean, White 
and Black African, White and Asian, other mixed). 
Hospital code (non- identifiable) was also extracted for 
analysis. Comorbidity data are entered as subjective free 
text by hospital teams. Text entries were searched for a 
record of donor hypertension using Stata to identify text 
“HYPERTENS”, “TENSION”, “HIGH BLOOD PRES-
SURE”, “INCREASED BLOOD PRESSURE”, “HIGH 
BP”, “HPN”, “RISE BP”. Entries recording “PULMO-
NARY HYPERTENSION” and “WHITE COAT” were not 
included as recording hypertension. Other comorbidities 
were listed infrequently: three individuals were recorded 
as having diabetes mellitus. Due to the low numbers for 
other comorbidities, only hypertension was included in 
the analysis.
statistical methods
Binary and categorical variables were described using 
frequencies and percentages. Means and SDs were calcu-
lated for normally distributed continuous variables. 
Medians and IQRs were calculated for continuous vari-
ables whose distribution was not normal. The χ2 test and 
one- way analysis of variance were used to compare donor 
characteristics over time and across ethnic groups.
Multivariable linear regression models (regression 
coefficients, 95% CIs and p values) were used to examine 
change in continuous variable donor characteristics 
(age and BMI) over time (across years of donation). 
Multivariable logistic regression models (ORs, 95% CIs 
and p values) were used to examine change in binary 
variable donor characteristics (sex, ethnicity: white vs 
other ethnic groups, and comorbidity: hypertension vs 
no hypertension) over time (across years of donation). 
Potential confounders for each model were identified 
a priori (reported alongside adjusted results). Living 
kidney donor assessment is carried out within renal and 
transplant units at NHS hospital trusts. As living kidney 
donors assessed in the same centre may be more similar 
than living kidney donors assessed at another centre, we 
derived robust standard errors to account for clustering 
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Total n=11 651 (%*)
Sex
   Female 6217 (53)
   Male 5428 (47)
   Missing 6 (0.05)
Age (years)
   <20 27 (0.2)
   20–29 1065 (9)
   30–39 2104 (18.8)
   40–49 3403 (29)
   50–59 3040 (26)
   60–69 1734 (15)
   70–79 259 (2)
   >80 13 (0.1)
   Missing 6 (0.05)
Ethnicity
   White 10 134 (87)
   Asian 838 (7)
   Black 409 (4)
   Chinese 60 (0.5)
   Mixed/other 198 (2)
   Missing 12 (0.1)
Body mass index (kg/m2)
   <18.5 84 (0.7)
   18.5–24.9 3851 (33)
   25.0–29.9 5233 (45)
   30.0–34.9 1822 (16)
   >35.0 207 (2)
   Missing 454 (4)
Relationship of donor to recipient
   Partner/spouse 2499 (22)
   Parent 2746 (24)
   Sibling 2692 (23)
   Child† 986 (9)
   Other living relative 466 (4)
   Other living non- relative 951 (8)
   ‘Altruistic’ non- directed 634 (5)
   Pooled donor‡ 670 (6)
   Missing 7 (0.06)
*Percentages were rounded up so total may>100%.
†Child in terms of relationship to recipient (son or daughter) not age.
‡From UK Living Kidney Sharing Scheme/paired exchange scheme.
by renal unit. Non- directed donors were excluded from 
the analysis of donor–recipient relationship.
All statistical analyses were carried out in Stata V.15.27 
We performed a complete case analysis and then under-
took a sensitivity analysis using multiple imputation 
using chained equations to derive 40 imputed data-
sets per group, for the exposure variable and potential 
confounders and then combined using Rubin’s rules 
using the multiple imputation procedure in Stata V.15.27 
The report was written with reference to The Strength-
ening the Reporting of Observational Studies in Epidemi-
ology Statement: guidelines for reporting observational 
studies.28 The clinical and research activities being 
reported are consistent with the Principles of the Declara-
tion of Istanbul as outlined in the ‘Declaration of Istanbul 
on Organ Trafficking and Transplant Tourism’.
results
Between January 2006 and December 2017, 11 651 LKDs 
were reported to NHSBT (table 1). The annual number 
of living kidney donations between 2006 and 2019 as 
reported by NHSBT is shown in figure 1.
Missing data
The amount of missing data was very small. Sex was 
missing for 0.05% of living donors, age was missing for 
0.05%, ethnicity was missing for 0.1% of participants, 
BMI missing for 3.6% and the relationship between the 
donor and the recipient was not recorded for 0.06% of 
directed donors.
sex
A greater proportion of donors were women (53%), 
but this proportion did not change significantly over 
time (online supplementary figure S1). There was weak 
evidence that the proportion of donors who are women 
varied between ethnic groups (χ2 p=0.05). There were 
more female donors than male donors across all ethnic 
groups apart from individuals whose ethnicity is classified 
as ‘black’ (table 2). Among this group, over the 12- year 
period more men than women donated.
Age
Between 2006 and 2017, the mean age of donors increased 
(unadjusted regression coefficient per 1+ year 0.23 (95% 
CI 0.12 to 0.33) p<0.001; figure 2). This association 
remained after adjustment for possible confounders sex 
and ethnicity (adjusted regression coefficient per 1+ year 
0.23 (95% CI 0.14 to 0.32) p<0.001).
The proportion of donors aged ≥65 years increased 
from 4% to 10% (p value for linear trend <0.001; table 3). 
The mean age of donors from black and Asian and ethnic 
groups was lower than in white groups (figure 3).
ethnicity
No difference in the number or proportion of donors 
from BAME ethnic groups was observed over the 12- year 
period (likelihood of donor being BAME vs white adjusted 
OR per 1+ year 1.00 (95% CI 0.93 to 1.08) p=0.93, p value 
for linear trend=0.61; figure 4 and table 4).
body mass index
Between 2006 and 2017, 18% of UK living kidney donors 
had a BMI ≥30 kg/m2 at donation (WHO category 
‘obese’; table 1). Mean BMI did not change over time 
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Figure 1 Number of UK living kidney donors 2006–2017.




Female (%) Male (%)
White 5410 (53) 4724 (47)
Asian 465 (56) 373 (45)
Black 193 (47) 216 (53)
Chinese 37 (62) 23 (38)
Mixed 107 (54) 91 (46)
Total 6212 (53) 5427 (47)
*Individuals with missing data for sex (n=6) and ethnicity (n=6) 
excluded.
Figure 2 Mean age of UK living kidney donors 2006–2017.
(unadjusted linear regression coefficient −0.02 (95% CI 
−0.05 to 0.02) p=0.29). There was weak evidence that 
mean BMI differed across ethnic groups (one- way anal-
ysis of variance p=0.04). This was largely as a result of the 
Chinese/South East Asian population having lower BMIs 
(online supplementary table S1).
blood pressure
A minority of donors had a diagnosis of high blood pres-
sure (3%). The proportion of donors with hypertension 
did not change over time (likelihood of donor having 
hypertension per 1+year OR 1.02 (95% CI 0.96 to 1.08) p 
value=0.47).
Donor–recipient relationship
The proportion of non- genetically related non- partner dona-
tions (eg, friends) increased over the 12- year period of 
analysis (p value for linear trend=0.002). There was 
evidence that the donor–recipient relationship differed 
between different ethnic groups (χ2 p<0.001, one- way 
analysis of variance p<0.001; table 5). A greater propor-
tion of black donors are siblings to their recipient, 
compared with all other ethnic groups.
The associations did not significantly differ between the 
complete cases analysis and the analyses with missing vari-
ables imputed (online supplementary table S2).
non-directed ‘altruistic’ donors
Between 2006 and 2017, 623 non- directed altruistic 
donors (NDAD) donated. There was a yearly increase 
in the number of NDAD donations from 2006 to 2014, 
before a subsequent drop and possible plateau (online 
supplementary figure S2). The mean age of NDADs was 
54 years (SD 14). The oldest NDAD was 85 years and the 
youngest was 20 years. There was no evidence that the 
mean age of NDADs differed between years of donation 
(p=0.6). Ninety- eight per cent of NDADs were white, and 
48% were women.
DIsCussIOn
We have described the characteristics of the cohort of 
individuals who donated kidneys in the UK between 2006 
and 2017. We have demonstrated that over the 12- year 
period the donor profile changed as a greater proportion 
of donations from older donors occurred: this change 
in donor profile has implications for both recipient and 
donor outcomes.
We have reported differences in donor characteristics 
across different ethnic groups: Black living kidney donors 
were younger than donors from all other ethnic groups, 
and a greater proportion were siblings to their recipients 
and were men. No change in the number of donations 
from BAME donors was observed.
In the UK, mean donor age increased between 2006 
and 2017, largely as a result of an increase in the propor-
tion of donors aged ≥65 years of age. This change may 
reflect that the UK population with kidney failure is 
ageing, and therefore their peer and potential donor pool 
is also older. Recent research from the USA has reported 
an interaction between ethnicity and age, suggesting that 
the risk of kidney failure 20 years after donation is higher 
in older White donors but higher in younger Black 
donors.29 30 Therefore, our findings of increasing age in 
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Table 3 Proportion of UK living kidney donors from different age groups 2006–2017
% Total number of living kidney donors per year
Age group (years) 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
18–34.9 16 17 16 16 21 18. 21 16 19 16 19 15
35–49.9 47 44 42 42 39 41 39 37 36 38 36 35
50–64.9 33 35 35 37 35 36 34 36 34 35 34 40
≥65 4 5 7 5 6 6 7 11 11 11 11 10
Figure 3 Mean age of UK living kidney donors by ethnic 
group. Figure 4 Ethnicity of UK living kidney donors 2006–2017.
the white donor pool, and the sustained low age of black 
donors have implications for both donor outcomes, and 
mandates robust living donor follow- up, in order to accu-
rately inform future living donors and clinicians as to the 
potential risks of donation. Why older BAME individuals 
are less likely to become living kidney donors warrants 
investigation.
ethnicity
Compared with the general UK population, patients 
from ethnic minority backgrounds are over- represented 
on the kidney transplant waiting list, with 34% of patients 
on the waiting list classified as being from BAME ethnic 
backgrounds, compared with 11% of the general popula-
tion.4 In this study, we found no evidence of an increase 
in the number or proportion of living donors from BAME 
groups between 2006 and 2017. In 2016, NHSBT in the 
UK commissioned the National BAME Transplant Alli-
ance to allocate funding to projects designed to increase 
the number of LDKTs among BAME communities in 
the UK. Twelve awards have been made to patient- led, 
clinical, and charitable groups31 to undertake projects 
including raising awareness in specific religious commu-
nities such as the Muslim Community in Yorkshire, and 
the Jain community in London, as well as the use of 
peer volunteers to engage patients and their families in 
discussions about living donation and transplantation at 
home.31 Strategies and interventions to increase donation 
from ethnic minority populations need to be thoroughly 
evaluated to ensure that we have good evidence as to both 
whether an intervention has been effective, and, equally 
importantly, how the intervention was effective. Along-
side this work further research is required to understand 
better the barriers that may be contributing to the ethnic 
inequity in donation and transplantation. Only with 
this understanding can evidence- based interventions be 
developed to increase donations from BAME individuals.
Findings from our cohort study were concerning 
regarding the current population of Black living donors. 
Black donors are already at a higher risk of developing 
kidney failure following donation,14 as are younger 
donors,14 men29 30 and those who are related to their 
recipient.12 In this study, we found that Black donors in 
the UK are younger than donors in other ethnic groups, 
more likely to be siblings of their recipient, and a greater 
proportion are men. The combination of these four 
higher risk factors means that Black donors in the UK may 
be at a much greater risk of developing kidney failure, 
and life- long follow- up and analysis of these outcomes for 
these donors is absolutely essential. Research to better 
understand the reasons for these ethnic differences is 
also required, as well as evaluation of whether and how 
these risks are communicated to potential donors.
body mass index
Mean donor BMI did not change over the period of 
analysis despite increasing obesity in the general popula-
tion.32 However, 18% of UK living kidney donors did have 
a BMI ≥30 kg/m2: a systematic review and meta‐analysis of 
short‐term outcomes for living donors identified a higher 









pen: first published as 10.1136/bm


























































































































































































































































































































































































































































































































































































































































































pen: first published as 10.1136/bm




7Bailey PK, et al. BMJ Open 2020;10:e033906. doi:10.1136/bmjopen-2019-033906
Open access
creatinine rise in obese donors with a BMI ≥30 kg/m2,33 
and analysis of Scientific Registry of Transplant Recip-
ients data has suggested that living kidney donors with 
a BMI >30 kg/m2 had an 86% increased risk of kidney 
failure compared with those with lower BMIs (adjusted 
HR 1.86; 95% CI 1.05 to 3.30).34 Whether UK donors 
with higher BMIs are adequately counselled regarding 
these increased risks should be investigated, in addition 
to determining their long- term outcomes.
Comparison with the other donor populations
An analysis of a registry of French living kidney donors 
(n=3877) has reported a similar increase in donor age 
between 2007 and 2017. As in our analysis, the French 
did not observe an increase in the BMIs of living donors, 
but a greater proportion of the UK donor population is 
obese compared with the French donor population (18% 
vs 11.3%). This may reflect the difference in prevalence 
of obesity between the two countries, but whether obese 
donors are accepted at all centres in France should be 
examined.35 Compared with the UK donor population, 
a greater proportion of French living kidney donors are 
women compared with the UK donor population (62.3% 
vs 53%).36
The UK living kidney donor population also differs 
in clinical and demographic characteristics to a corre-
sponding population of USA living kidney donors.13 37 38 
A greater proportion of living kidney donations in the UK 
are from older donors than in the USA: in an analysis 
of USA living donors from 1994 to 2011, only 4.2% of 
donors were 60 years or older,13 compared with 17.3% in 
this cohort.
A greater proportion of living kidney donors in the 
USA are from non- white individuals (25.4% in USA 
cohort vs 13.0% in the UK).13 As in our study, non- white 
donors in the USA are more likely to be younger than 
white donors.37 A greater proportion of living donors in 
the USA are obese (BMI ≥30 kg/m2) at donation (25.2% 
in USA vs 17.4% in UK).13
Our understanding of the risks of donation is largely 
based on USA data.13 14 30 39 Compared with USA data, the 
UK population of living kidney donors is older, less ethni-
cally diverse, with a smaller proportion of donors classi-
fied as obese. These differences limit the generalisability 
of USA donor risk data from observational research to 
the UK population. Therefore, we would expect the inci-
dence of kidney failure after donation to be lower in the 
UK than in the USA.
Future research
Further research is required to understand if differences 
in the donor populations of different ethnic groups are 
due to the choices and preferences of the donor popu-
lation or due to the influence of clinicians and clinical 
practice policies.
Living kidney donation and transplantation occurs in a 
dynamic environment: in addition to emerging research 
on the long- term risks of donation, the UK’s economic 
climate and its government policy and legislation change. 
England will move to an ‘opt- out’ system of deceased 
organ donation in 2020: previous studies have shown that 
a move to an opt- out policy can have a negative impact on 
numbers of living kidney donations40 and therefore the 
impact of this change on living kidney donations must be 
monitored.
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